Table 2.
Participants carrying APOE E3E3 and E3E4 in CN Group
2a Number of participants by APOE status | ||||||||||||||
APOE | bl | m0 | m1 | m2 | m3 | m4 | m6 | |||||||
Status | 6 | 2 | 4 | 6 | 8 | 0 | ||||||||
E3E3 | 158 | 157 | 152 | 145 | 83 | 124 | 71 | |||||||
E3E4 | 62 | 60 | 60 | 59 | 29 | 47 | 26 | |||||||
2b Number of participants by APOE status and risk score | ||||||||||||||
Characteristics | bl | bl | m0 | m0 | m1 | m1 | m2 | m2 | m3 | m3 | m4 | m4 | m6 | m6 |
6 | 6 | 2 | 2 | 4 | 4 | 6 | 6 | 8 | 8 | 0 | 0 | |||
APOE | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E | E3E |
Status | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 |
High | 45 | 58 | 45 | 56 | 42 | 56 | 39 | 55 | 19 | 26 | 33 | 44 | 20 | 23 |
Low | 113 | 4 | 112 | 4 | 110 | 4 | 106 | 4 | 64 | 3 | 91 | 3 | 51 | 3 |
bl: baseline; m: month. Thus month 6 is represented by m06